CIK 0000818033 · Accelerated filer
HERON THERAPEUTICS, INC. /DE/
Sign in to watch- Ticker
- HRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 942875566
- Phone
- 8582514400
- Business address
- 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-30 | MANHARD KIMBERLY EVP, Drug Development | Other acquisition | +1,529 | $13.90 | $21K | 3,163 |
| 2021-04-15 | Christian Waage Director | Sale | −300 | $17.51 | $5K | 4,100 |
| 2021-04-13 | Szekeres David Leslie EVP, Chief Operating Officer | Option exercise | +1,250 | 1,250 | ||
| 2021-04-13 | Szekeres David Leslie EVP, Chief Operating Officer | Shares withheld for taxes | −433 | $16.66 | $7K | 817 |
| 2021-04-13 | Szekeres David Leslie EVP, Chief Operating Officer | Option exercise · Restricted Stock Units | −1,250 | 17,500 | ||
| 2021-04-13 | Quart Barry D Chief Executive Officer | Option exercise | +3,646 | 96,155 | ||
| 2021-04-13 | Quart Barry D Chief Executive Officer | Shares withheld for taxes | −963 | $16.66 | $16K | 95,192 |
| 2021-04-13 | Quart Barry D Chief Executive Officer | Option exercise · Restricted Stock Units | −3,646 | 51,041 | ||
| 2021-04-13 | POYHONEN JOHN President & CCO | Option exercise | +1,250 | 20,847 | ||
| 2021-04-13 | POYHONEN JOHN President & CCO | Shares withheld for taxes | −433 | $16.66 | $7K | 20,414 |
| 2021-04-13 | POYHONEN JOHN President & CCO | Option exercise · Restricted Stock Units | −1,250 | 17,500 | ||
| 2021-04-13 | Peraza Lisa VP, Chief Accounting Officer | Option exercise | +552 | 12,136 | ||
| 2021-04-13 | Peraza Lisa VP, Chief Accounting Officer | Shares withheld for taxes | −191 | $16.66 | $3K | 11,945 |
| 2021-04-13 | Peraza Lisa VP, Chief Accounting Officer | Option exercise · Restricted Stock Units | −552 | 7,729 | ||
| 2021-04-13 | MANHARD KIMBERLY EVP, Drug Development | Option exercise | +1,250 | 2,067 | ||
| 2021-04-13 | MANHARD KIMBERLY EVP, Drug Development | Shares withheld for taxes | −433 | $16.66 | $7K | 1,634 |
| 2021-04-13 | MANHARD KIMBERLY EVP, Drug Development | Option exercise · Restricted Stock Units | −1,250 | 17,500 | ||
| 2021-04-06 | Johnson Craig A Director | Sale | −250 | $17.22 | $4K | 3,590 |
| 2021-01-14 | Szekeres David Leslie EVP, Chief Operating Officer | Sale | −827 | $18.09 | $15K | 0 |
| 2021-01-13 | Szekeres David Leslie EVP, Chief Operating Officer | Option exercise | +1,250 | 1,250 |
Page 27 of 28 · 557 trades